VAERS 2412016
PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge FK98933579
- Staat
- FL
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 16.08.2022
- Impfdatum
- 04.04.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- - / LA
Symptomtext
covid-19; covid-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 71-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 19Jan2021 at 13:30 as dose 1, single (Lot number: EL3246), in left arm, on 09Feb2021 at 13:30 as dose 2, single (Lot number: EL9265), in left arm, on 27Sep2021 at 16:15 as dose 3 (booster), single (Lot number: 301358A), in left arm and on 04Apr2022 at 13:15 as dose 4 (booster), single (Lot number: FK98933579) at the age of 71 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "EBV" (unspecified if ongoing); "Asthma" (unspecified if ongoing); "HTN" (unspecified if ongoing); "Fibromyalgia" (unspecified if ongoing); "Hyperlipemmia" (unspecified if ongoing); "Diverticulosis with Bowel resection" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Demerol, reaction(s): "known allergies"; Erythromycin, reaction(s): "known allergies"; Gabapentin, reaction(s): "known allergies"; Statins, reaction(s): "known allergies". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), all with latency 9 days after the suspect product(s) administration, outcome "unknown" and all described as "covid-19". The patient underwent the following laboratory tests and procedures: Body temperature: (30Jul2022) 104 Centigrade, notes: Day 0 temp104degree, High; (31Jul2022) 103 Centigrade, notes: Day 1 Temp 103degree, High; (08Aug2022) 101.4 Centigrade, notes: Day 9 rebound temp101.4degree, High; SARS-CoV-2 test: (unspecified date) Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of vaccination failure, covid-19. Additional information: Paxlovid was used from 30Jul2022 to 03Aug2022 for the treatment of COVID-19. Adverse event: Day 0 temp 104degree, chills, severe Headache, eye ache. Muscle and joint pain Bronchitis type cough mild SOB with exertion (Hx Asthma), phlegm clear the yellow malaise. Day 1 Temp 103degree. Afebrile with Tylenol. Continued cough, malaise, joint and muscle pain. Day2 slight improvement. No loss of taste/ smell continued cough some nausea with paxlovid. Symbicourt increased to 2 puffs bid, Albuterol q8degree. Day 9 rebound temp101.4degree severe HA, body/joint pain eye ache cold symptoms runny nose, sneezing loss taste/smell test Pos. Adverse event start date: 08Aug2022 12:00AM. Patient was not recovered and no treatment was received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201053725 Same patient, different product and event;
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Body temperature
- Hospital-Tage
- -
- Labordaten
- Test Date: 20220730; Test Name: Body Temperature; Result Unstructured Data: Test Result:104 Centigrade; Comments: Day 0 temp104degree, High; Test Date: 20220731; Test Name: Body Temperature; Result Unstructured Data: Test Result:103 Centigrade; Comments: Day 1 Temp 103degree, High; Test Date: 20220808; Test Name: Body Temperature; Result Unstructured Data: Test Result:101.4 Centigrade; Comments: Day 9 rebound temp101.4degree, High; Test Name: covid-19 test; Test Result: Positive ; Comments: COVID 19 Treatment
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Asthma; Bowel resection; EBV hepatitis; Fibromyalgia; Hyperlipaemia; Hypertension
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -